Gross Profit On Sales 更改
Adcock Ingram Holdings ZAR 1.54B 73.26M 2024-12
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Celltrion KRW 442.87B 100.93B 2025-03
Cspc Pharmaceutical CNY 4.71B 391.66M 2025-03
Dianthus Therapeutics 1.16M 164K 2025-03
Divis Laboratories Ltd 14.54B 1.5B 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
Glaxosmithkline GBP 5.6B 94M 2024-12
Kangmei Pharma CNY 223.73M 38.54M 2025-03
Knight Therapeutics CAD 45.02M 2.32M 2024-09
Laboratorios Farma EUR 282.36M 172.04M 2024-12
Malin Corporation EUR 3.8M 2.6M 2020-12
Medical Developments International AUD 14.72M 1.36M 2024-12
Merck USD 12.99B 224M 2025-06
Novartis USD 10.24B 313M 2024-12
Organigram Holdings CAD 1.05M 67.34M 2024-12
Organon & Co USD 874M 33M 2025-06
Pharma Mar EUR 53.61M 18.15M 2025-06
Qiagen NV USD 334.29M 25.6M 2025-06
Sartorius EUR 416.2M 14.8M 2025-06
Sino Biopharmaceutical CNY 10.5B 2.53B 2024-12
Tilray USD 61.22M 1.51M 2024-11


Organon & Co 销售毛利 - 当前值,历史数据,预测,统计,图表和经济日历 - Aug 2025.